Meridian Bioscience Inc (NASDAQ:VIVO)

20.47
Delayed Data
As of May 07
 +1.30 / +6.78%
Today’s Change
12.98
Today|||52-Week Range
30.65
+9.52%
Year-to-Date

Today’s Trading

Previous close19.17
Today’s open19.06
Day’s range18.89 - 20.74
Volume27,943
Average volume (3 months)737,551
Market cap$881.0M
Data as of 3:59pm ET, 05/07/2021

Growth & Valuation

Earnings growth (last year)+88.18%
Earnings growth (this year)+60.05%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+26.19%
P/E ratio12.7
Price/Sales2.89
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
TRILTrillium Therapeutic...+0.31+3.34%
CLDXCelldex Therapeutics...+0.69+2.60%
AWHAspira Women's Healt...+0.27+5.49%
----
Data as of 4:00pm ET, 05/07/2021

Financials

Next reporting dateJuly 29, 2021
EPS forecast (this quarter)$0.35
Annual revenue (last year)$253.7M
Annual profit (last year)$46.2M
Net profit margin18.21%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cincinnati, Ohio

Forecasts